Literature DB >> 1398684

Human hybridoma generation by hypo-osmolar electrofusion: characterization of human monoclonal antibodies to Schistosoma mansoni parasite antigens.

G Klock1, A V Wisnewski, E A el-Bassiouni, M I Ramadan, P Gessner, U Zimmermann, T F Kresina.   

Abstract

Human monoclonal antibodies which bind Schistosoma mansoni worm and egg antigens were identified and characterized from hybridomas generated using the hypo-osmolar electrofusion technique of somatic cell fusion. Splenocytes from S. mansoni infected individuals were mitogen-activated in vitro and subsequently fused by electrofusion. The greatest number of HAT resistant hybridomas per helical fusion chamber was obtained with unfrozen splenocytes cultured for 4-6 days after introduction of mitogen. Hybridomas secreting IgG antibodies recognizing parasite antigens were identified by ELISA. Twenty-one cloned cell lines secreting IgG antibody were maintained for at least 6 months. Characterization of antigen reactivity by Western blot analysis of nien cloned cell lines revealed antibodies which bound stage specific parasitic antigens. The data show that the technique of hypo-osmolar electrofusion produces stable, antibody producing hybridomas. The human monoclonal antibodies screened represent candidate molecules useful in the investigations of the human pathogen S. mansoni.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1398684     DOI: 10.1089/hyb.1992.11.469

Source DB:  PubMed          Journal:  Hybridoma        ISSN: 0272-457X


  2 in total

1.  The systematic study of the electroporation and electrofusion of B16-F1 and CHO cells in isotonic and hypotonic buffer.

Authors:  Marko Usaj; Masa Kanduser
Journal:  J Membr Biol       Date:  2012-07-29       Impact factor: 1.843

2.  In vitro inhibition of Cryptosporidium parvum infection by human monoclonal antibodies.

Authors:  B C Elliot; A V Wisnewski; J Johnson; D Fenwick-Smith; P Wiest; D Hamer; T Kresina; T P Flanigan
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.